Showing results 8 to 13 of 13
< previous
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
Pegylated Recombinant Human Arginase 1 Induces Autophagy and Apoptosis via the ROS-Activated AKT/mTOR Pathway in Bladder Cancer Cells Journal:Oxidative Medicine and Cellular Longevity | Editor(s):Quiles, JL | 2021 | 12 | |
Pegylated recombinant human hepatic arginase I (rhArg-peg 5,000 mw) inhibits human hepatocellular carcinoma in vitro and in vivo Proceeding/Conference:The International Meeting of Hepatocellular Carcinoma | 2004 | 109 | ||
| 2009 | 183 | |||
Remission of hepatocellular carcinoma with Arginine depletion induced by systemic release of endogenous hepatic arginase due to transheaptic embolization augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma Proceeding/Conference:The International Meeting of Hepatocellular Carcinoma | 2004 | 89 | ||
| 2005 | 107 | |||
Suppression of tumour growth by pegylated arginase in malignant pleural mesothelioma Proceeding/Conference:Journal of Thoracic Oncology | 2017 | 44 |